Rappaport Reiches Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $283K | Buy |
568
+14
| +3% | +$6.97K | 0.07% | 93 |
|
|
2024
Q4 | $288K | Sell |
554
-2
| -0.4% | -$1.04K | 0.07% | 82 |
|
|
2024
Q3 | $344K | Buy |
556
+2
| +0.4% | +$1.24K | 0.09% | 76 |
|
|
2024
Q2 | $306K | Buy |
554
+10
| +2% | +$5.53K | 0.09% | 73 |
|
|
2024
Q1 | $316K | Buy |
544
+1
| +0.2% | +$581 | 0.1% | 80 |
|
|
2023
Q4 | $288K | Buy |
543
+129
| +31% | +$68.5K | 0.11% | 62 |
|
|
2023
Q3 | $210K | Buy |
414
+1
| +0.2% | +$506 | 0.09% | 70 |
|
|
2023
Q2 | $215K | Hold |
413
| – | – | 0.09% | 73 |
|
|
2023
Q1 | $238K | Hold |
413
| – | – | 0.11% | 71 |
|
|
2022
Q4 | $227K | Buy |
413
+1
| +0.2% | +$551 | 0.11% | 68 |
|
|
2022
Q3 | $209K | Hold |
412
| – | – | 0.11% | 68 |
|
|
2022
Q2 | $224K | Buy |
+412
| New | +$224K | 0.11% | 70 |
|